Advertisement

Index by author

January 01, 2001; Volume 29,Issue 1

A

  1. Agrawal, Arun K.

    1. Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms
      Nisar A. Pampori, Arun K. Agrawal and Bernard H. Shapiro
      Drug Metabolism and Disposition January 2001, 29 (1) 8-16;

B

  1. Ball, Simon E.

    1. A Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an in Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry
      Elizabeth A. Dierks, Karen R. Stams, Heng-Keang Lim, Georgia Cornelius, Honglu Zhang and Simon E. Ball
      Drug Metabolism and Disposition January 2001, 29 (1) 23-29;

  2. Bapiro, Tashinga E.

    1. Application of Higher Throughput Screening (HTS) Inhibition Assays to Evaluate the Interaction of Antiparasitic Drugs with Cytochrome P450s
      Tashinga E. Bapiro, Ann-Charlotte Egnell, Julia A. Hasler and Collen M. Masimirembwa
      Drug Metabolism and Disposition January 2001, 29 (1) 30-35;

  3. Beaumont, Kevin

    1. Use of Cloned and Expressed Human UDP-Glucuronosyltransferases for the Assessment of Human Drug Conjugation and Identification of Potential Drug Interactions
      Brian T. Ethell, Kevin Beaumont, David J. Rance and Brian Burchell
      Drug Metabolism and Disposition January 2001, 29 (1) 48-53;

  4. Blom, Maarten J.

    1. Metabolism of Estradiol, Ethynylestradiol, and Moxestrol in Rat Uterus, Vagina, and Aorta: Influence of Sex Steroid Treatment
      Maarten J. Blom, Marjolein Groot Wassink, Helenius J. Kloosterboer, Antwan G. H. Ederveen, Jan G. D. Lambert and Henk J. Th. Goos
      Drug Metabolism and Disposition January 2001, 29 (1) 76-81;

  5. Bonacorsi, Samuel

    1. Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
      Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
      Drug Metabolism and Disposition January 2001, 29 (1) 60-69;

  6. Burchell, Brian

    1. Use of Cloned and Expressed Human UDP-Glucuronosyltransferases for the Assessment of Human Drug Conjugation and Identification of Potential Drug Interactions
      Brian T. Ethell, Kevin Beaumont, David J. Rance and Brian Burchell
      Drug Metabolism and Disposition January 2001, 29 (1) 48-53;

C

  1. Caggana, Michele

    1. Identification of a New Human CYP2A Gene Fragment with Close Linkage to CYP2GP1
      Jiangjun Sheng, Zichun Hua, Jiancheng Guo, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition January 2001, 29 (1) 4-7;

  2. Chapman, Kevin

    1. P450 Interaction with HIV Protease Inhibitors: Relationship between Metabolic Stability, Inhibitory Potency, and P450 Binding Spectra
      Masato Chiba, Lixia Jin, William Neway, Joseph P. Vacca, James R. Tata, Kevin Chapman and Jiunn H. Lin
      Drug Metabolism and Disposition January 2001, 29 (1) 1-3;

  3. Chiba, Kan

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

  4. Chiba, Masato

    1. P450 Interaction with HIV Protease Inhibitors: Relationship between Metabolic Stability, Inhibitory Potency, and P450 Binding Spectra
      Masato Chiba, Lixia Jin, William Neway, Joseph P. Vacca, James R. Tata, Kevin Chapman and Jiunn H. Lin
      Drug Metabolism and Disposition January 2001, 29 (1) 1-3;

  5. Chung, Suk-Jae

    1. The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers
      Hong Li, Suk-Jae Chung, Dong-Chool Kim, Hyun-Soo Kim, Jong-Wook Lee and Chang-Koo Shim
      Drug Metabolism and Disposition January 2001, 29 (1) 54-59;

  6. Cornelius, Georgia

    1. A Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an in Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry
      Elizabeth A. Dierks, Karen R. Stams, Heng-Keang Lim, Georgia Cornelius, Honglu Zhang and Simon E. Ball
      Drug Metabolism and Disposition January 2001, 29 (1) 23-29;

D

  1. Dierks, Elizabeth A.

    1. A Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an in Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry
      Elizabeth A. Dierks, Karen R. Stams, Heng-Keang Lim, Georgia Cornelius, Honglu Zhang and Simon E. Ball
      Drug Metabolism and Disposition January 2001, 29 (1) 23-29;

  2. Ding, Xinxin

    1. Identification of a New Human CYP2A Gene Fragment with Close Linkage to CYP2GP1
      Jiangjun Sheng, Zichun Hua, Jiancheng Guo, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition January 2001, 29 (1) 4-7;

E

  1. Ederveen, Antwan G. H.

    1. Metabolism of Estradiol, Ethynylestradiol, and Moxestrol in Rat Uterus, Vagina, and Aorta: Influence of Sex Steroid Treatment
      Maarten J. Blom, Marjolein Groot Wassink, Helenius J. Kloosterboer, Antwan G. H. Ederveen, Jan G. D. Lambert and Henk J. Th. Goos
      Drug Metabolism and Disposition January 2001, 29 (1) 76-81;

  2. Egnell, Ann-Charlotte

    1. Application of Higher Throughput Screening (HTS) Inhibition Assays to Evaluate the Interaction of Antiparasitic Drugs with Cytochrome P450s
      Tashinga E. Bapiro, Ann-Charlotte Egnell, Julia A. Hasler and Collen M. Masimirembwa
      Drug Metabolism and Disposition January 2001, 29 (1) 30-35;

  3. Ethell, Brian T.

    1. Use of Cloned and Expressed Human UDP-Glucuronosyltransferases for the Assessment of Human Drug Conjugation and Identification of Potential Drug Interactions
      Brian T. Ethell, Kevin Beaumont, David J. Rance and Brian Burchell
      Drug Metabolism and Disposition January 2001, 29 (1) 48-53;

G

  1. Guo, Jiancheng

    1. Identification of a New Human CYP2A Gene Fragment with Close Linkage to CYP2GP1
      Jiangjun Sheng, Zichun Hua, Jiancheng Guo, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition January 2001, 29 (1) 4-7;

H

  1. Hasler, Julia A.

    1. Application of Higher Throughput Screening (HTS) Inhibition Assays to Evaluate the Interaction of Antiparasitic Drugs with Cytochrome P450s
      Tashinga E. Bapiro, Ann-Charlotte Egnell, Julia A. Hasler and Collen M. Masimirembwa
      Drug Metabolism and Disposition January 2001, 29 (1) 30-35;

  2. Hauer, Michael J.

    1. Interaction of Delavirdine with Human Liver Microsomal Cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6
      Richard L. Voorman, N. Ann Payne, Larry C. Wienkers, Michael J. Hauer and Phillip E. Sanders
      Drug Metabolism and Disposition January 2001, 29 (1) 41-47;

  3. Hua, Zichun

    1. Identification of a New Human CYP2A Gene Fragment with Close Linkage to CYP2GP1
      Jiangjun Sheng, Zichun Hua, Jiancheng Guo, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition January 2001, 29 (1) 4-7;

I

  1. Ishizaki, Takashi

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

  2. Iyer, Ramaswamy A.

    1. Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
      Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
      Drug Metabolism and Disposition January 2001, 29 (1) 60-69;

J

  1. Jin, Lixia

    1. P450 Interaction with HIV Protease Inhibitors: Relationship between Metabolic Stability, Inhibitory Potency, and P450 Binding Spectra
      Masato Chiba, Lixia Jin, William Neway, Joseph P. Vacca, James R. Tata, Kevin Chapman and Jiunn H. Lin
      Drug Metabolism and Disposition January 2001, 29 (1) 1-3;

K

  1. Kardar, Sean S.

    1. Characterization of Cyp4a Induction in Rat Liver by Inflammatory Stimuli: Dependence on Sex, Strain, and Inflammation-Evoked Hypophagia
      Stephanie R. Mitchell, Marion B. Sewer, Sean S. Kardar and Edward T. Morgan
      Drug Metabolism and Disposition January 2001, 29 (1) 17-22;

  2. Kim, Dong-Chool

    1. The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers
      Hong Li, Suk-Jae Chung, Dong-Chool Kim, Hyun-Soo Kim, Jong-Wook Lee and Chang-Koo Shim
      Drug Metabolism and Disposition January 2001, 29 (1) 54-59;

  3. Kim, Hyun-Soo

    1. The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers
      Hong Li, Suk-Jae Chung, Dong-Chool Kim, Hyun-Soo Kim, Jong-Wook Lee and Chang-Koo Shim
      Drug Metabolism and Disposition January 2001, 29 (1) 54-59;

  4. Kloosterboer, Helenius J.

    1. Metabolism of Estradiol, Ethynylestradiol, and Moxestrol in Rat Uterus, Vagina, and Aorta: Influence of Sex Steroid Treatment
      Maarten J. Blom, Marjolein Groot Wassink, Helenius J. Kloosterboer, Antwan G. H. Ederveen, Jan G. D. Lambert and Henk J. Th. Goos
      Drug Metabolism and Disposition January 2001, 29 (1) 76-81;

  5. Kobayashi, Kaoru

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

  6. Kogo, Mari

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

  7. Kripalani, Kishin

    1. Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
      Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
      Drug Metabolism and Disposition January 2001, 29 (1) 60-69;

  8. Kuroiwa, Yukio

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

L

  1. Lambert, Jan G. D.

    1. Metabolism of Estradiol, Ethynylestradiol, and Moxestrol in Rat Uterus, Vagina, and Aorta: Influence of Sex Steroid Treatment
      Maarten J. Blom, Marjolein Groot Wassink, Helenius J. Kloosterboer, Antwan G. H. Ederveen, Jan G. D. Lambert and Henk J. Th. Goos
      Drug Metabolism and Disposition January 2001, 29 (1) 76-81;

  2. Lee, Jong-Wook

    1. The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers
      Hong Li, Suk-Jae Chung, Dong-Chool Kim, Hyun-Soo Kim, Jong-Wook Lee and Chang-Koo Shim
      Drug Metabolism and Disposition January 2001, 29 (1) 54-59;

  3. Levy, Mark A.

    1. Development of an in Vivo Preclinical Screen Model to Estimate Absorption and Bioavailability of Xenobiotics
      Keith W. Ward, Joel W. Proksch, Mark A. Levy and Brian R. Smith
      Drug Metabolism and Disposition January 2001, 29 (1) 82-88;

  4. Li, Hong

    1. The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers
      Hong Li, Suk-Jae Chung, Dong-Chool Kim, Hyun-Soo Kim, Jong-Wook Lee and Chang-Koo Shim
      Drug Metabolism and Disposition January 2001, 29 (1) 54-59;

  5. Lim, Heng-Keang

    1. A Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an in Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry
      Elizabeth A. Dierks, Karen R. Stams, Heng-Keang Lim, Georgia Cornelius, Honglu Zhang and Simon E. Ball
      Drug Metabolism and Disposition January 2001, 29 (1) 23-29;

  6. Lin, Jiunn H.

    1. P450 Interaction with HIV Protease Inhibitors: Relationship between Metabolic Stability, Inhibitory Potency, and P450 Binding Spectra
      Masato Chiba, Lixia Jin, William Neway, Joseph P. Vacca, James R. Tata, Kevin Chapman and Jiunn H. Lin
      Drug Metabolism and Disposition January 2001, 29 (1) 1-3;

M

  1. Malhotra, Bimal

    1. Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
      Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
      Drug Metabolism and Disposition January 2001, 29 (1) 60-69;

  2. Masimirembwa, Collen M.

    1. Application of Higher Throughput Screening (HTS) Inhibition Assays to Evaluate the Interaction of Antiparasitic Drugs with Cytochrome P450s
      Tashinga E. Bapiro, Ann-Charlotte Egnell, Julia A. Hasler and Collen M. Masimirembwa
      Drug Metabolism and Disposition January 2001, 29 (1) 30-35;

  3. Mitchell, Stephanie R.

    1. Characterization of Cyp4a Induction in Rat Liver by Inflammatory Stimuli: Dependence on Sex, Strain, and Inflammation-Evoked Hypophagia
      Stephanie R. Mitchell, Marion B. Sewer, Sean S. Kardar and Edward T. Morgan
      Drug Metabolism and Disposition January 2001, 29 (1) 17-22;

  4. Mitroka, James

    1. Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
      Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
      Drug Metabolism and Disposition January 2001, 29 (1) 60-69;

  5. Morgan, Edward T.

    1. Characterization of Cyp4a Induction in Rat Liver by Inflammatory Stimuli: Dependence on Sex, Strain, and Inflammation-Evoked Hypophagia
      Stephanie R. Mitchell, Marion B. Sewer, Sean S. Kardar and Edward T. Morgan
      Drug Metabolism and Disposition January 2001, 29 (1) 17-22;

N

  1. Neway, William

    1. P450 Interaction with HIV Protease Inhibitors: Relationship between Metabolic Stability, Inhibitory Potency, and P450 Binding Spectra
      Masato Chiba, Lixia Jin, William Neway, Joseph P. Vacca, James R. Tata, Kevin Chapman and Jiunn H. Lin
      Drug Metabolism and Disposition January 2001, 29 (1) 1-3;

  2. Numazawa, Satoshi

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

P

  1. Pampori, Nisar A.

    1. Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms
      Nisar A. Pampori, Arun K. Agrawal and Bernard H. Shapiro
      Drug Metabolism and Disposition January 2001, 29 (1) 8-16;

  2. Payne, N. Ann

    1. Interaction of Delavirdine with Human Liver Microsomal Cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6
      Richard L. Voorman, N. Ann Payne, Larry C. Wienkers, Michael J. Hauer and Phillip E. Sanders
      Drug Metabolism and Disposition January 2001, 29 (1) 41-47;

  3. Proksch, Joel W.

    1. Development of an in Vivo Preclinical Screen Model to Estimate Absorption and Bioavailability of Xenobiotics
      Keith W. Ward, Joel W. Proksch, Mark A. Levy and Brian R. Smith
      Drug Metabolism and Disposition January 2001, 29 (1) 82-88;

R

  1. Rance, David J.

    1. Use of Cloned and Expressed Human UDP-Glucuronosyltransferases for the Assessment of Human Drug Conjugation and Identification of Potential Drug Interactions
      Brian T. Ethell, Kevin Beaumont, David J. Rance and Brian Burchell
      Drug Metabolism and Disposition January 2001, 29 (1) 48-53;

  2. Rinehart, J. Kent

    1. Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
      Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
      Drug Metabolism and Disposition January 2001, 29 (1) 60-69;

  3. Roongta, Vikram A.

    1. Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
      Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
      Drug Metabolism and Disposition January 2001, 29 (1) 60-69;

S

  1. Sanders, Phillip E.

    1. Interaction of Delavirdine with Human Liver Microsomal Cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6
      Richard L. Voorman, N. Ann Payne, Larry C. Wienkers, Michael J. Hauer and Phillip E. Sanders
      Drug Metabolism and Disposition January 2001, 29 (1) 41-47;

  2. Schrag, Michael L.

    1. Triazolam Substrate Inhibition: Evidence of Competition for Heme-Bound Reactive Oxygen Within the CYP3A4 Active Site
      Michael L. Schrag and Larry C. Wienkers
      Drug Metabolism and Disposition January 2001, 29 (1) 70-75;

  3. Sewer, Marion B.

    1. Characterization of Cyp4a Induction in Rat Liver by Inflammatory Stimuli: Dependence on Sex, Strain, and Inflammation-Evoked Hypophagia
      Stephanie R. Mitchell, Marion B. Sewer, Sean S. Kardar and Edward T. Morgan
      Drug Metabolism and Disposition January 2001, 29 (1) 17-22;

  4. Shapiro, Bernard H.

    1. Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms
      Nisar A. Pampori, Arun K. Agrawal and Bernard H. Shapiro
      Drug Metabolism and Disposition January 2001, 29 (1) 8-16;

  5. Sheng, Jiangjun

    1. Identification of a New Human CYP2A Gene Fragment with Close Linkage to CYP2GP1
      Jiangjun Sheng, Zichun Hua, Jiancheng Guo, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition January 2001, 29 (1) 4-7;

  6. Shim, Chang-Koo

    1. The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers
      Hong Li, Suk-Jae Chung, Dong-Chool Kim, Hyun-Soo Kim, Jong-Wook Lee and Chang-Koo Shim
      Drug Metabolism and Disposition January 2001, 29 (1) 54-59;

  7. Shimada, Noriaki

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

  8. Smith, Brian R.

    1. Development of an in Vivo Preclinical Screen Model to Estimate Absorption and Bioavailability of Xenobiotics
      Keith W. Ward, Joel W. Proksch, Mark A. Levy and Brian R. Smith
      Drug Metabolism and Disposition January 2001, 29 (1) 82-88;

  9. Stams, Karen R.

    1. A Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an in Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry
      Elizabeth A. Dierks, Karen R. Stams, Heng-Keang Lim, Georgia Cornelius, Honglu Zhang and Simon E. Ball
      Drug Metabolism and Disposition January 2001, 29 (1) 23-29;

T

  1. Tani, Masayoshi

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

  2. Tata, James R.

    1. P450 Interaction with HIV Protease Inhibitors: Relationship between Metabolic Stability, Inhibitory Potency, and P450 Binding Spectra
      Masato Chiba, Lixia Jin, William Neway, Joseph P. Vacca, James R. Tata, Kevin Chapman and Jiunn H. Lin
      Drug Metabolism and Disposition January 2001, 29 (1) 1-3;

  3. Th. Goos, Henk J.

    1. Metabolism of Estradiol, Ethynylestradiol, and Moxestrol in Rat Uterus, Vagina, and Aorta: Influence of Sex Steroid Treatment
      Maarten J. Blom, Marjolein Groot Wassink, Helenius J. Kloosterboer, Antwan G. H. Ederveen, Jan G. D. Lambert and Henk J. Th. Goos
      Drug Metabolism and Disposition January 2001, 29 (1) 76-81;

V

  1. Vacca, Joseph P.

    1. P450 Interaction with HIV Protease Inhibitors: Relationship between Metabolic Stability, Inhibitory Potency, and P450 Binding Spectra
      Masato Chiba, Lixia Jin, William Neway, Joseph P. Vacca, James R. Tata, Kevin Chapman and Jiunn H. Lin
      Drug Metabolism and Disposition January 2001, 29 (1) 1-3;

  2. Voorman, Richard L.

    1. Interaction of Delavirdine with Human Liver Microsomal Cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6
      Richard L. Voorman, N. Ann Payne, Larry C. Wienkers, Michael J. Hauer and Phillip E. Sanders
      Drug Metabolism and Disposition January 2001, 29 (1) 41-47;

W

  1. Waller, Stephen C.

    1. Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
      Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
      Drug Metabolism and Disposition January 2001, 29 (1) 60-69;

  2. Ward, Keith W.

    1. Development of an in Vivo Preclinical Screen Model to Estimate Absorption and Bioavailability of Xenobiotics
      Keith W. Ward, Joel W. Proksch, Mark A. Levy and Brian R. Smith
      Drug Metabolism and Disposition January 2001, 29 (1) 82-88;

  3. Wassink, Marjolein Groot

    1. Metabolism of Estradiol, Ethynylestradiol, and Moxestrol in Rat Uterus, Vagina, and Aorta: Influence of Sex Steroid Treatment
      Maarten J. Blom, Marjolein Groot Wassink, Helenius J. Kloosterboer, Antwan G. H. Ederveen, Jan G. D. Lambert and Henk J. Th. Goos
      Drug Metabolism and Disposition January 2001, 29 (1) 76-81;

  4. Wienkers, Larry C.

    1. Interaction of Delavirdine with Human Liver Microsomal Cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6
      Richard L. Voorman, N. Ann Payne, Larry C. Wienkers, Michael J. Hauer and Phillip E. Sanders
      Drug Metabolism and Disposition January 2001, 29 (1) 41-47;
    2. Triazolam Substrate Inhibition: Evidence of Competition for Heme-Bound Reactive Oxygen Within the CYP3A4 Active Site
      Michael L. Schrag and Larry C. Wienkers
      Drug Metabolism and Disposition January 2001, 29 (1) 70-75;

Y

  1. Yamamoto, Toshinori

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

  2. Yoshida, Takemi

    1. Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
      Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
      Drug Metabolism and Disposition January 2001, 29 (1) 36-40;

Z

  1. Zhang, Honglu

    1. A Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an in Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry
      Elizabeth A. Dierks, Karen R. Stams, Heng-Keang Lim, Georgia Cornelius, Honglu Zhang and Simon E. Ball
      Drug Metabolism and Disposition January 2001, 29 (1) 23-29;
Back to top

In this issue